ATE133412T1 - Nichtpeptidyl integrin inhibitoren mit spezifität für den gpiib iiia rezeptor - Google Patents
Nichtpeptidyl integrin inhibitoren mit spezifität für den gpiib iiia rezeptorInfo
- Publication number
- ATE133412T1 ATE133412T1 AT92922468T AT92922468T ATE133412T1 AT E133412 T1 ATE133412 T1 AT E133412T1 AT 92922468 T AT92922468 T AT 92922468T AT 92922468 T AT92922468 T AT 92922468T AT E133412 T1 ATE133412 T1 AT E133412T1
- Authority
- AT
- Austria
- Prior art keywords
- nonpeptidyl
- specificity
- iiia receptor
- integrin inhibitors
- gpiib iiia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D267/14—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78147791A | 1991-10-18 | 1991-10-18 | |
| US07/866,931 US5250679A (en) | 1991-10-18 | 1992-04-10 | Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE133412T1 true ATE133412T1 (de) | 1996-02-15 |
Family
ID=27119863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92922468T ATE133412T1 (de) | 1991-10-18 | 1992-10-15 | Nichtpeptidyl integrin inhibitoren mit spezifität für den gpiib iiia rezeptor |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US5250679A (de) |
| EP (1) | EP0610334B1 (de) |
| JP (2) | JP3789468B2 (de) |
| AT (1) | ATE133412T1 (de) |
| AU (1) | AU673501B2 (de) |
| CA (1) | CA2119745C (de) |
| DE (1) | DE69207916T2 (de) |
| DK (1) | DK0610334T3 (de) |
| ES (1) | ES2085651T3 (de) |
| FI (1) | FI941222A7 (de) |
| GE (1) | GEP20032957B (de) |
| GR (1) | GR3019517T3 (de) |
| MD (1) | MD960330A (de) |
| NO (1) | NO307417B1 (de) |
| WO (1) | WO1993008174A1 (de) |
Families Citing this family (107)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2703408B2 (ja) * | 1990-12-28 | 1998-01-26 | 麒麟麦酒株式会社 | １，４‐ベンゾチアゼピン誘導体 |
| US5645815A (en) | 1991-02-08 | 1997-07-08 | Diatide, Inc. | Radiolabled compounds for thrombus imaging |
| US5736122A (en) * | 1991-02-08 | 1998-04-07 | Diatide, Inc. | Technetium-99m labeled peptides for thrombus imaging |
| ATE188387T1 (de) * | 1991-02-08 | 2000-01-15 | Diatide Inc | Technetium-99m markierte polypeptide zur bildformung |
| US6019958A (en) * | 1991-02-08 | 2000-02-01 | Diatide, Inc. | Technetium-99m labeled peptides for imaging inflammation |
| AU666318B2 (en) * | 1991-06-28 | 1996-02-08 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
| US5939412A (en) * | 1992-06-26 | 1999-08-17 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
| US5663166A (en) * | 1991-10-18 | 1997-09-02 | Genentech, Inc. | Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor |
| US5750754A (en) * | 1993-03-29 | 1998-05-12 | Zeneca Limited | Heterocyclic compounds |
| GB9406144D0 (en) * | 1993-03-29 | 1994-05-18 | Zeneca Ltd | Heterocyclic compounds |
| US5652242A (en) * | 1993-03-29 | 1997-07-29 | Zeneca Limited | Heterocyclic derivatives |
| US5753659A (en) * | 1993-03-29 | 1998-05-19 | Zeneca Limited | Heterocyclic compouds |
| WO1994022834A1 (en) * | 1993-03-29 | 1994-10-13 | Zeneca Limited | Heterocyclic derivatives as platelet aggregation inhibitors |
| ZA942439B (en) * | 1993-04-08 | 1996-01-08 | Diatech Inc | Radiolabeled compounds for thrombus imaging |
| US5463011A (en) * | 1993-06-28 | 1995-10-31 | Zeneca Limited | Acid derivatives |
| GB9313285D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Acid derivatives |
| GB9313268D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Chemical compounds |
| IL110172A (en) * | 1993-07-22 | 2001-10-31 | Lilly Co Eli | Bicyclic compounds and pharmaceutical compositions containing them |
| US6137002A (en) | 1993-07-22 | 2000-10-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
| US6448269B1 (en) | 1993-07-22 | 2002-09-10 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
| US5731324A (en) * | 1993-07-22 | 1998-03-24 | Eli Lilly And Company | Glycoprotein IIb/IIIa antagonists |
| US5493020A (en) * | 1993-07-29 | 1996-02-20 | Genentech, Inc. | Tricyclic inhibitors of the GPIIb IIIa receptor |
| CA2134192A1 (en) * | 1993-11-12 | 1995-05-13 | Michael L. Denney | 5, 6-bicyclic glycoprotein iib/iiia antagonists |
| DE4341665A1 (de) * | 1993-12-07 | 1995-06-08 | Basf Ag | Bicyclen-Derivate, ihre Herstellung und Verwendung |
| US6403578B1 (en) | 1993-12-21 | 2002-06-11 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
| MA23420A1 (fr) * | 1994-01-07 | 1995-10-01 | Smithkline Beecham Corp | Antagonistes bicycliques de fibrinogene. |
| ZA955391B (en) * | 1994-06-29 | 1996-02-09 | Smithkline Beecham Corp | Vitronectin receptor antagonists |
| US6458784B1 (en) | 1994-06-29 | 2002-10-01 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
| AU702661B2 (en) * | 1994-06-29 | 1999-02-25 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
| EP0796252A4 (de) * | 1994-12-09 | 1998-02-04 | Smithkline Beecham Corp | Bicyclische fibrinogen antagonisten |
| US5639765A (en) * | 1995-01-17 | 1997-06-17 | G. D. Searle & Co. | Guanidinoalkyl glycine β-amino acids useful for inhibiting bone loss |
| US5977101A (en) * | 1995-06-29 | 1999-11-02 | Smithkline Beecham Corporation | Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity |
| JP2000502354A (ja) * | 1995-12-29 | 2000-02-29 | スミスクライン・ビーチャム・コーポレイション | ビトロネクチン受容体アンタゴニスト |
| US6107300A (en) * | 1996-03-27 | 2000-08-22 | Dupont Pharmaceuticals | Arylamino fused pyrimidines |
| DK0894084T3 (da) * | 1996-03-29 | 2002-10-14 | Searle & Co | Kanelsyrederivater og deres anvendelse som integrinantagonister |
| DK0914605T3 (da) | 1996-07-25 | 2007-09-10 | Biogen Idec Inc | Molekylemodel for VLA-4-inhibitorer |
| CN1478472A (zh) * | 1996-07-25 | 2004-03-03 | ¸ | 细胞粘连抑制剂 |
| US6686350B1 (en) * | 1996-07-25 | 2004-02-03 | Biogen, Inc. | Cell adhesion inhibitors |
| US20030125317A1 (en) | 1996-10-02 | 2003-07-03 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
| PE32799A1 (es) * | 1996-12-25 | 1999-04-09 | Agrogene Ltd | Nuevo derivado del acido aminobutirico para la proteccion de enfermedades fungosas |
| US7109326B2 (en) | 1997-04-15 | 2006-09-19 | Genentech, Inc. | Halo-alkoxycarbonyl prodrugs |
| DE69830577T2 (de) * | 1997-04-15 | 2006-05-04 | Genentech, Inc., South San Francisco | Halo-alkoxycarbonylverbindungen |
| US6197794B1 (en) | 1998-01-08 | 2001-03-06 | Celltech Therapeutics Limited | Phenylalanine derivatives |
| US6329372B1 (en) | 1998-01-27 | 2001-12-11 | Celltech Therapeutics Limited | Phenylalanine derivatives |
| EP1054877A1 (de) * | 1998-02-11 | 2000-11-29 | Du Pont Pharmaceuticals Company | Cyclische sulfonamid-derivate als metallprotease-inhibitoren |
| ATE273273T1 (de) | 1998-02-26 | 2004-08-15 | Celltech Therapeutics Ltd | Phenylalaninderivate als inhibitoren von alpha4 integrinen |
| US6136804A (en) | 1998-03-13 | 2000-10-24 | Merck & Co., Inc. | Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions |
| JP2002506024A (ja) * | 1998-03-13 | 2002-02-26 | メルク エンド カムパニー インコーポレーテッド | 急性冠動脈虚血症候群および関連状態に対する併用療法および組成物 |
| GB9805655D0 (en) | 1998-03-16 | 1998-05-13 | Celltech Therapeutics Ltd | Chemical compounds |
| US6521626B1 (en) | 1998-03-24 | 2003-02-18 | Celltech R&D Limited | Thiocarboxamide derivatives |
| WO1999050249A2 (en) | 1998-04-01 | 1999-10-07 | Du Pont Pharmaceuticals Company | Pyrimidines and triazines as integrin antagonists |
| GB9811159D0 (en) | 1998-05-22 | 1998-07-22 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9811969D0 (en) | 1998-06-03 | 1998-07-29 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9812088D0 (en) | 1998-06-05 | 1998-08-05 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9814414D0 (en) | 1998-07-03 | 1998-09-02 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9821061D0 (en) | 1998-09-28 | 1998-11-18 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9821222D0 (en) * | 1998-09-30 | 1998-11-25 | Celltech Therapeutics Ltd | Chemical compounds |
| GB9825652D0 (en) | 1998-11-23 | 1999-01-13 | Celltech Therapeutics Ltd | Chemical compounds |
| US6204282B1 (en) | 1998-11-30 | 2001-03-20 | Schering Corporation | Benzimidazole compounds that are vitronectin receptor antagonists |
| GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
| US6339083B1 (en) | 1998-12-14 | 2002-01-15 | Bayer Aktiengesellschaft | Multiheterocyclic pharmAceuticals |
| US6511649B1 (en) | 1998-12-18 | 2003-01-28 | Thomas D. Harris | Vitronectin receptor antagonist pharmaceuticals |
| EP1140864A2 (de) | 1998-12-18 | 2001-10-10 | Du Pont Pharmaceuticals Company | Pharmazeutische zusammensetzungen, vitronectinrezeptor antagonisten enthaltend |
| US6569402B1 (en) | 1998-12-18 | 2003-05-27 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
| EP1028114A1 (de) | 1999-02-13 | 2000-08-16 | Aventis Pharma Deutschland GmbH | Neue Guanidin-Derivate als Inhibitoren der Zelladhäsion |
| US6171578B1 (en) * | 1999-04-14 | 2001-01-09 | Diatide, Inc. | Benzodiazepine derivatives for imaging thrombi |
| US6518283B1 (en) | 1999-05-28 | 2003-02-11 | Celltech R&D Limited | Squaric acid derivatives |
| WO2001004103A1 (en) | 1999-07-13 | 2001-01-18 | F. Hoffmann-La Roche Ag | Benzazepinones and quinazolines |
| EE200200070A (et) * | 1999-08-13 | 2003-04-15 | Biogen, Inc. | Raku adhesiooni inhibiitorid |
| US6514964B1 (en) * | 1999-09-27 | 2003-02-04 | Amgen Inc. | Fused cycloheptane and fused azacycloheptane compounds and their methods of use |
| US6534513B1 (en) | 1999-09-29 | 2003-03-18 | Celltech R&D Limited | Phenylalkanoic acid derivatives |
| DE10028575A1 (de) * | 2000-06-14 | 2002-03-14 | Basf Ag | Integrinliganden |
| US6455539B2 (en) | 1999-12-23 | 2002-09-24 | Celltech R&D Limited | Squaric acid derivates |
| DE60130910T2 (de) | 2000-04-17 | 2008-07-10 | Ucb Pharma, S.A. | Enamin-derivate als zell-adhäsionsmoleküle |
| US6545013B2 (en) | 2000-05-30 | 2003-04-08 | Celltech R&D Limited | 2,7-naphthyridine derivatives |
| US6403608B1 (en) | 2000-05-30 | 2002-06-11 | Celltech R&D, Ltd. | 3-Substituted isoquinolin-1-yl derivatives |
| JP2004502762A (ja) | 2000-07-07 | 2004-01-29 | セルテック アール アンド ディ リミテッド | 二環性ヘテロ芳香環を含有するインテグリンアンタゴニストとしてのスクエア酸誘導体 |
| JP2004505110A (ja) | 2000-08-02 | 2004-02-19 | セルテック アール アンド ディ リミテッド | ３位置換イソキノリン−１−イル誘導体 |
| JP2004525109A (ja) | 2001-02-15 | 2004-08-19 | キング・ファーマシューティカルズ・インコーポレイティッド | 安定化された甲状腺ホルモン医薬組成物、及びその製法 |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| ES2309209T3 (es) | 2001-11-13 | 2008-12-16 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | 1,4-benzodiazepinas sustituidas y uso de las mismas para el tratamiento del cancer. |
| US7078409B2 (en) * | 2002-03-28 | 2006-07-18 | Beta Pharma, Inc. | Fused quinazoline derivatives useful as tyrosine kinase inhibitors |
| WO2004052364A1 (en) | 2002-12-06 | 2004-06-24 | The Trustees Of Boston University | METHODS FOR SUSTAINING eNOS ACTIVITY |
| US7196112B2 (en) | 2004-07-16 | 2007-03-27 | Biogen Idec Ma Inc. | Cell adhesion inhibitors |
| KR101594898B1 (ko) | 2005-07-15 | 2016-02-18 | 알바니 몰레큘라 리써치, 인크. | 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도 |
| JP5368792B2 (ja) | 2005-07-29 | 2013-12-18 | レスバーロジックス コーポレイション | 複合疾患の予防および処置のための薬学的組成物および挿入可能な医療用デバイスによるその送達 |
| DK2118074T3 (en) | 2007-02-01 | 2014-03-10 | Resverlogix Corp | Compounds for the prevention and treatment of cardiovascular diseases |
| US20090012103A1 (en) | 2007-07-05 | 2009-01-08 | Matthew Abelman | Substituted heterocyclic compounds |
| KR101629356B1 (ko) | 2008-06-26 | 2016-06-13 | 리스버로직스 코퍼레이션 | 퀴나졸리논 유도체의 제조방법 |
| WO2010053757A1 (en) | 2008-10-29 | 2010-05-14 | Gilead Palo Alto, Inc. | 2 -oxoquinoxalin blockers of the late sodium channel |
| WO2010074807A1 (en) | 2008-10-30 | 2010-07-01 | Gilead Palo Alto, Inc. | 3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators |
| WO2010056865A1 (en) | 2008-11-14 | 2010-05-20 | Gilead Palo Alto, Inc. | Quinoline derivatives as ion channel modulators |
| NZ594332A (en) | 2009-01-08 | 2013-09-27 | Resverlogix Corp | Compounds for the prevention and treatment of cardiovascular disease |
| KR101709492B1 (ko) | 2009-03-18 | 2017-02-23 | 리스버로직스 코퍼레이션 | 신규한 소염제 |
| US9757368B2 (en) | 2009-04-22 | 2017-09-12 | Resverlogix Corp. | Anti-inflammatory agents |
| PT2464645T (pt) | 2009-07-27 | 2017-10-11 | Gilead Sciences Inc | Compostos heterocíclicos fusionados como moduladores do canal de iões |
| WO2012003392A1 (en) | 2010-07-02 | 2012-01-05 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| AU2012253653A1 (en) | 2011-05-10 | 2013-05-02 | Gilead Sciences, Inc. | Fused heterocyclic compounds as sodium channel modulators |
| NO3175985T3 (de) | 2011-07-01 | 2018-04-28 | ||
| AU2015224425B2 (en) * | 2011-07-01 | 2017-02-09 | Gilead Sciences, Inc. | Fused benzoxazepinones as ion channel modulators |
| TWI622583B (zh) * | 2011-07-01 | 2018-05-01 | 基利科學股份有限公司 | 作為離子通道調節劑之稠合雜環化合物 |
| AU2013201608B9 (en) * | 2011-07-01 | 2015-07-23 | Gilead Sciences, Inc. | Fused benzoxazepinones as ion channel modulators |
| RU2640115C2 (ru) | 2011-11-01 | 2017-12-26 | Ресверлоджикс Корп. | Фармацевтические композиции замещенных хиназолинонов |
| WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
| US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
| US9271978B2 (en) | 2012-12-21 | 2016-03-01 | Zenith Epigenetics Corp. | Heterocyclic compounds as bromodomain inhibitors |
| US10111885B2 (en) | 2015-03-13 | 2018-10-30 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3371085A (en) * | 1959-12-10 | 1968-02-27 | Hoffmann La Roche | 5-aryl-3h-1,4-benzodiazepin-2(1h)-ones |
| US3374264A (en) * | 1962-10-04 | 1968-03-19 | Hoffmann La Roche | N-haloacetyl-anthranilic acids and esters |
| GB1124133A (en) * | 1964-10-02 | 1968-08-21 | Abbott Lab | Substituted 1,4-benzodiazepine-2,5-diones |
| US3415814A (en) * | 1966-09-28 | 1968-12-10 | Sterling Drug Inc | 4-(cyclopropylmethyl)-3h-1,4-benzodiazepine-2,5(1h,4h)-dione |
| DE1918072A1 (de) * | 1969-04-09 | 1970-10-15 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von 1-substituierten 4-Alkyl-3H-1,4-benzodiazepin-2,5-[1H,4H]-dionen |
| US3551414A (en) * | 1969-05-16 | 1970-12-29 | United States Steel Corp | 6,7-dihydro-5h-dibenz(c,e)azepin-7-ones |
| CA1143728A (en) * | 1979-10-04 | 1983-03-29 | Max Gerecke | Imidazodiazepine derivatives |
| CA1174673A (en) * | 1981-02-27 | 1984-09-18 | Walter Hunkeler | Imidazodiazepines |
| CA1184175A (en) * | 1981-02-27 | 1985-03-19 | Walter Hunkeler | Imidazodiazepines |
| US4585768A (en) * | 1984-04-10 | 1986-04-29 | Tanabe Seiyaku Co., Ltd. | 1,5-benzothiazepine derivatives and processes for preparing the same |
| US4689326A (en) * | 1985-10-17 | 1987-08-25 | Research Corporation | Process for controlling hyperlipidemia |
| CA1319144C (en) * | 1986-11-14 | 1993-06-15 | Quirico Branca | Tetrahydronaphthalene derivatives |
| EP0322779A3 (de) * | 1987-12-29 | 1991-05-08 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzolaktam-Verbindungen und deren pharmazeutische Verwendungen |
| ZW6189A1 (en) * | 1988-05-09 | 1990-05-09 | Smithkline Beckman Corp | Anti-aggregatory peptides |
| US5039805A (en) * | 1988-12-08 | 1991-08-13 | Hoffmann-La Roche Inc. | Novel benzoic and phenylacetic acid derivatives |
| US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
| CA2008116C (en) * | 1989-02-23 | 2001-11-20 | Thomas Weller | Glycine derivatives |
| FR2645744B1 (fr) * | 1989-04-13 | 1994-01-21 | Roussel Uclaf | Derives de la benzothiazepine, leur procede de preparation et les intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant |
| US5318899A (en) * | 1989-06-16 | 1994-06-07 | Cor Therapeutics, Inc. | Platelet aggregation inhibitors |
| US5384309A (en) * | 1989-07-17 | 1995-01-24 | Genentech, Inc. | Cyclized peptides and their use as platelet aggregation inhibitors |
| US5061693A (en) * | 1989-07-28 | 1991-10-29 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| FR2652352A1 (fr) * | 1989-09-28 | 1991-03-29 | Jouveinal Sa | Benzodiazepines, leur procede et intermediaires de preparation et leurs applications en therapeutique. |
| NZ235564A (en) * | 1989-10-13 | 1993-10-26 | Merck & Co Inc | Fibrinogen receptor antagonist and pharmaceutical compositions |
| AU6470590A (en) * | 1989-10-23 | 1991-04-26 | Smithkline Beecham Corporation | Cyclic anti-aggregatory peptides |
| US5053392A (en) * | 1989-12-01 | 1991-10-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Novel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitors |
| JPH0747582B2 (ja) * | 1989-12-11 | 1995-05-24 | 杏林製薬株式会社 | キナゾリン―３―アルカン酸誘導体とその塩およびその製造法 |
| DE69126871T2 (de) * | 1990-04-06 | 1998-03-12 | Jolla Cancer Res Found | Verfahren und verbindung zur behandlung von thrombose |
| DE4102024A1 (de) * | 1991-01-24 | 1992-07-30 | Thomae Gmbh Dr K | Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| AU666318B2 (en) * | 1991-06-28 | 1996-02-08 | Smithkline Beecham Corporation | Bicyclic fibrinogen antagonists |
| RU2124503C1 (ru) * | 1992-05-18 | 1999-01-10 | И.Р.Сквибб энд Санз, Инк. | Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция |
-
1992
- 1992-04-10 US US07/866,931 patent/US5250679A/en not_active Expired - Lifetime
- 1992-10-15 AU AU27976/92A patent/AU673501B2/en not_active Expired
- 1992-10-15 MD MD96-0330A patent/MD960330A/ro unknown
- 1992-10-15 WO PCT/US1992/008788 patent/WO1993008174A1/en not_active Ceased
- 1992-10-15 EP EP92922468A patent/EP0610334B1/de not_active Expired - Lifetime
- 1992-10-15 ES ES92922468T patent/ES2085651T3/es not_active Expired - Lifetime
- 1992-10-15 AT AT92922468T patent/ATE133412T1/de active
- 1992-10-15 DE DE69207916T patent/DE69207916T2/de not_active Expired - Lifetime
- 1992-10-15 CA CA002119745A patent/CA2119745C/en not_active Expired - Lifetime
- 1992-10-15 JP JP50779093A patent/JP3789468B2/ja not_active Expired - Lifetime
- 1992-10-15 GE GEAP19922402A patent/GEP20032957B/en unknown
- 1992-10-15 FI FI941222A patent/FI941222A7/fi unknown
- 1992-10-15 DK DK92922468.1T patent/DK0610334T3/da active
-
1993
- 1993-05-06 US US08/058,722 patent/US5403836A/en not_active Expired - Lifetime
-
1994
- 1994-04-15 NO NO941378A patent/NO307417B1/no not_active IP Right Cessation
-
1996
- 1996-04-02 GR GR960400905T patent/GR3019517T3/el unknown
-
2003
- 2003-04-08 JP JP2003104672A patent/JP2003300962A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GEP20032957B (en) | 2003-04-25 |
| US5250679A (en) | 1993-10-05 |
| JP3789468B2 (ja) | 2006-06-21 |
| MD960330A (ro) | 1998-05-31 |
| ES2085651T3 (es) | 1996-06-01 |
| JPH07500341A (ja) | 1995-01-12 |
| FI941222L (fi) | 1994-06-02 |
| DE69207916D1 (de) | 1996-03-07 |
| FI941222A7 (fi) | 1994-06-02 |
| CA2119745C (en) | 2007-02-20 |
| AU673501B2 (en) | 1996-11-14 |
| EP0610334B1 (de) | 1996-01-24 |
| NO941378L (no) | 1994-06-20 |
| FI941222A0 (fi) | 1994-03-15 |
| NO941378D0 (no) | 1994-04-15 |
| WO1993008174A1 (en) | 1993-04-29 |
| US5403836A (en) | 1995-04-04 |
| GR3019517T3 (en) | 1996-07-31 |
| NO307417B1 (no) | 2000-04-03 |
| AU2797692A (en) | 1993-05-21 |
| DK0610334T3 (da) | 1996-06-03 |
| JP2003300962A (ja) | 2003-10-21 |
| CA2119745A1 (en) | 1993-04-29 |
| DE69207916T2 (de) | 1996-10-17 |
| EP0610334A1 (de) | 1994-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69207916D1 (de) | Nichtpeptidyl integrin inhibitoren mit spezifität für den gpiib iiia rezeptor | |
| ATE153665T1 (de) | Tricyclische inhibitoren von gp ii b iii a rezeptoren | |
| NO933999L (no) | Fibrinogenreseptorantagonister | |
| ATE299890T1 (de) | Inhibitoren von gamma-secretase | |
| NL300808I2 (nl) | susoctocog alfa | |
| ES2157337T3 (es) | Derivados de morfolina y su uso como agentes terapeuticos. | |
| UY26957A1 (es) | Nuevos agentes anticolinérgicos que se pueden emplear como medicamentos así como procedimiento para su preparación | |
| FI962749A0 (fi) | Uusia heterosyklisiä yhdisteitä | |
| ATE166222T1 (de) | Medizinische artikel | |
| ATE506959T1 (de) | Verwendung von il-18 inhibitoren | |
| NZ516513A (en) | Nitric oxide donors for inducing neurogenesis | |
| DK58291D0 (da) | Krystalinsk stof og dets fremstilling | |
| DE60121986D1 (de) | Triptpolidanaloge zur verendung in der behandlung von autoimmunbedingten und entzündlichen erkrankungen | |
| IT1269185B (it) | Associazione dotata di effetto sinergico che ha un effetto antagonista dei recettori nk1 e nk2 | |
| CO5011051A1 (es) | Compuesto de carbapenem, uso del mismo y sus compuestos intermedios | |
| AR025224A1 (es) | Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma | |
| ES2044100T3 (es) | Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos. | |
| NO20006699D0 (no) | Forbindelser med veksthormonfrigjörende egenskaper | |
| UY26329A1 (es) | Antagonistas de los receptores de vitronectina | |
| DE60119285D1 (de) | Verwendung von plgf zur vorbeugung oder behandlung von ischaemie oder schlaganfall | |
| DE50010972D1 (de) | UBICHINON Qn ZUR BEHANDLUNG VON MIGRÄNESCHMERZEN | |
| ATE339217T1 (de) | Caseinoglycomacropeptide zur inhibierung der adhäsion von pathogener flora auf der haut | |
| ES2088693T3 (es) | Uso de composiciones para el tratamiento de tejidos. | |
| ES2093515T3 (es) | Aplicacion del riluzol como radio-restaurador. | |
| NO20012169D0 (no) | Forbindelser med veksthormonfrigjörende egenskaper |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |